Personal Information
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.emdmillipore.com
À propos
At MilliporeSigma, one of the top three investors in R&D in the Life Science Tools industry, we develop cutting-edge technologies and services for bioscience research and biopharmaceutical manufacturing. Innovation drives everything we do. And it’s reinforced by our collaborative culture, pioneering spirit and unwavering focus on the world’s most challenging human health issues.
The life science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada.
Mots-clés
milliporesigma
merck
bioprocessing
formulation
regulatory
next generation bioprocessing
biopharmaceutical manufacturing
single-use
downstream processing
biopharmaceuticals
cell culture media
cell culture
continuous bioprocessing
monoclonal antibody
process development- biomanufacturing
sterile filtration
chromatography
webinar
gene therapy
upstream processing
pharmaceutical
bioreactor
clarification
tangential flow filtration
biomanufacturing
biosafety
cell line development
cell & gene therapy
final fill
biosafety testing
solid formulation
purification
process intensification
single-use systems
excipients
patient safety
filtration
contract dev & mfg
viral clearance
viral safety
mabs
risk assessment
integrity testing
antibody drug conjugate
regulatory guidelines
next generation processing
vaccine manufacturing
clarification/harvest
manufacturing
vaccines
bioreliance
virus removal
risk mitigation
final sterile filtration
ultrafiltration
diafiltration
active pharmaceutical ingredient
drug development
viral contamination
cell therapies
adcs
biologics safety
virus detection
regulatory considerations
raw materials
process mabs
biopharma
product recovery
adc
ultrafiltration/diafiltration & concentration
aav
adeno-associated viruses (aav)
chromatography purification
pharma
chromatography resins
cell and gene therapy
buffer & media prep
harvest
monoclonal antibodies
adeno-associated virus
product characterization
sterilization
life science
scale up
conjugation
virus
viral vector manufacturing
perfusion
pharmacetuical process development
extractables and leachables
continuous processing
viscosity reducing excipients
sterile filtration & bioburden control
downstream
mrna vaccines
cell therapy
sterile sampling
mab
ccm
e2e
api
biosafety services
cell line
risk management
viral vector
chozn
adventitious virus contamination
tech transfer
perfusion media
biosimilars
vaccine processing
viscosity reducing agents
viscosity reducing additives
therapeutic protein formulations
subcutaneous formulation development
reformulating protein biotherapeutics
protein viscosity
iv to subq
iv to sc
intravenous to subcutaneous
intramuscular injection
intradermal injection
high concentration protein formulations
biotherapeutic formulation
quality by design
protein stability
healthcare
continuous manufacturing
virus inactivation
pupsit
covid-19
drug delivery
upstream process
single-use bioreactors
chemistry
tff
single use
bioprocess development
sptff
collaboration
plasma
training
regulatory requirements
lentivirus
quality
novel therapies
emprove
molecule
case study
cho
biotechnology
seed train
cell culture seed train
process validation
bioburden
qbd
cmo
upstream and downstream processing
contract manufacturing
large scale cell culture
extractables
bpog
intravenous injection
regulatory/validation
validation
bioburden control
3d printing
single-pass tff
media filtration
upstream
mrna therapies
research
automation
bioprocess orchestration software
solid dose
depth filtration
downstream purification
single-use technology
fluid management
chromatography/purification
api synthesis
sterilizing filtration
host cell protein
gene therapy manufacturing
regulatory affairs / validation
solubility enhancement
cell line characterization
education and training
innovation
aseptic filter
bioavailability
excipient
liquid formulation
usp <665>
toxicology
regulatory documentation
virus prevention
cgmp
hmscs
stem cells
human mesenchymal stromal
operator safety
next-gen processing
flocculation
protein purification
protein aggregation
automation system
a&f
vlp
subhasis banerjee
somasundaram g
liquid dosage form
lipopolysaccharide
fine chemicals
endotoxin removal
endotoxin control and clearance
endotoxin contamination
contamination control strategy
chetosensartm
maycoretm
dolcoretm
viscosity reduction platform
josephine cheng
bacterial fermentation
cld
mab development
biopharmaceutical
formulations
aav therapy
emprove® api
chemical synthesis
solid dosage
replication competent virus
dry granulation
3d printing technology
fc-fusion protein
pdadmac
concentration
mrna manufacturing process
mrna
cation exchange chromatography
biocontinuum
nanoparticulate impurities
recombinant protein
biologics
pdna
plasmid dna
filter integrity testing
buffer
anion exchange chromatography
flow-through polishing
microfiltration
bioburden reduction
normal flow filtration
pva
active pharmaceutical ingredients
advanced drug delivery
drug release
vgt
lipid based rna
car-t
stability enhancement
facility of the future
process development
active and formulation
dsp platform
viral & gene (vgt) therapy manufacturing
sterile filtration / prefiltration
draft annex 1
biologics manufacturing
provantage biodevt & e2e services
mesoporous silica formulations
mesoporous silica technology
amorphous formulation
mesoporous silica
lot release testing
gmp cell banking
activated pegs
peg
membrane chromatography
natrix
pcr
supply chain
viral therapies
gene editing
filter
polyvinyl alcohol
hot melt extrusion
semi-solid formulation
solid dosage drug formulation
api stability
clinical development
cell bank
lipid nanoparticles
lipids
zika
microcarrier
mscs
protein a membrane
chromatpgraphy
in vitro
bioreliance services
fda
chozn gs-/- expression system
viral product manufacturing
sterilizing grade filter
emerging biotech
biotech process
final fill vial
virus safety
adventitious virus
testing considerations
continuous process
biologic drugs
scalability
high viscosity tff
tablet coating polyvinyl
tablet coating
tio2 alternative
titanium dioxide alternative
tio2
titanium dioxide
calcium carbonate
parteck ta
increase lifetime
resin performance
cleaning efficiency
protein a column
eshmuno
naoh
cleaning in place
cip
ethylene glycol
cation exchange
protein a
excipient impact
protein stabilization
particle formation
agitation stress
protein solutions
surfactants
api processing
cocrystal formation
salt formation
api solubility
spike protein
sars-cov-2
sac
equipment qualification
cdc
adcc
actives and formulation
regulatory expectations
biophorum
pharma raw material risk
extractables risk assessment
leachables risk assessment
pharmaceutical risk management
filtration technology
extractables data
remote audit
remote
virtual technology
technology
audits
audit
qc testing
gmp
gene therapies
therapeutic medicine
viral gene therapy
ngs assays
ngs
identity testing
large scale manufacturing
melt based 3d
melt based
polymers
3d
t cell
ekko™ select system
dmso
car-t manufacturing
acoustic cell processing syste
ekko™
virus testing
q5a
ich q5a
process orchestration
operational efficiency
product quality
process orchestrator
bio4c
covid-19 pandemic
west african pandemic
technovax
innovative biotech
sars-cov-2 vaccine
cov-2 vaccines
vaccine collaboration
virus like particle
x-ray
x-ray sterilization
rca assay
adenoviral vectors
rca testing
high intensity sweeteners
sucralose
neotame
types of oral dosage form
tablets dosage forms
solid pharmaceutical dosage form
solid dose pharmaceuticals
solid dosage formulation
solid dosage forms include
oral solid dosage forms
pharmaceutical solid dosage forms
types of oral solid dosage forms
oral solid dosage
oral solid
oral solid dosage manufacturing
oral dosage forms
formulation of tablet dosage form
dosage form of tablet
adc express™
hydrophilicity
adc payloads
adcore product line
small scale
adcs adc therapies solubility
risk of cross-contamination
sterile medicinal products
eu gmp annex 1 draft
sf9 rhabdovirus-negative
sf-rvn
performant rhabdovirus-free
bevs
baculovirus expression vector
complex injectables
viscous formulations
nanoparticles
liposomes
viscosity reducing excipient
protein viscosity on syringeability
innovative technologies in biomolecule formulation
helium integrity testing
helium
sterilizing grade filters
lysis
viral vector therapy
pva in ophthalmics
ophthalmic formulation
ophthalmics
ophthalmic excipients
excipient flowability
dust formation of chemicals
reduced caking excipients
free flowing excipients
pharma manufacturing efficiency
dry granulated excipients
roller compaction raw materials
compacted excipients
granulated pharmaceutical raw materials
viral clearance studies
virus bank services
virus filters
recombinant production
recombinant development
mab production
paul genest
filter performance
filter virus removal
optimize filter virus removal
filter capacity
parvovirus filtration
product safety
stability testing
edmund ang
janice tan
chozn expression platform
cd cloning media
subsequent bioprocess
chemistry manufacturing controls
cmc
chemically defined cloning media
production cell line
upstream process develoment
adc therapies
dolastin
giuseppe camporeale
ashok kumar
payload intermediate
linker-payload
speed up
high-potent payloads
leo ohrem
solid dose formulation
xiaolong sun
trends in vaccine manufacturing
quality management systems qmss
jerome dalin
pharma grade sugar
excipient(s)
polyol(s)
low npi sucrose
bulking agent biomolecules
pharma(ceutical) grade sucrose
sucrose pharmaceutical excipient
stabilize biomolecules
syringability
subcutaneous administration
subq
reduce viscosity
synergistic effects
formation
virus inactivation steps
thierry burnouf
subcutaneous igg infusion
scalable plasma process
safety and quality of plasma igg
removal of solvent
removal of detergent
purification process
plasma immunoglobulin purification
plasma igg
fractionation flow
flow-through-mode chromatography
flow-through purification
aseptic filtration
affinity chromatography
buffer and media prep
fc-fusion
chozn-gs system
chozn gs
chozn-gs
bacterial retention testing
validation services
vaccine technologies
vaccine development and manufacturing
vaccine development
novel vaccine development
human therapy
stemline®
bone marrow
ex vivo cell expansion
media formulation
human mesenchymal stromal/stem cells
gmp-compliant
mesenchymal stem cell growth
mesenchymal
xeno free culture
high yields
e&l
process validation strategy
risk-based approach
technology transfer
cdmo
end to end
nanoparticulate
impurities
sucrose
excipent
protein
handling challenges
capsid protein
cqa
critical quality attributes
orthogonal method
orthogonal methods
technically unavoidable particle profiles
tupp
emprove® chemicals
emprove®
stem cell
xeno free
preclinical
: ex vivo
lsm
laser scanning microscopy
optical coherence technology
coating formulation development
oct
particle designed pva
coating process
coating
bio4csuite
software and automation
saa
software
closed processing
single-use tff
hc agnostic
hcp id
hcp
host cell protein impurities
biotherapy purity
host cell proteins
mass spectrometry
cellculture
filterselection
cellculturemedia
mediafiltration
powder feeding
cm
electrostatic charge
crazy powder
(qc) test methods
mycoplasma
methods for sterility
quality control testing
test methods
compen-dial
proteins
peptides
injectables
antibodies
viral inactivation
filaments
sterility assurance
roller compaction
granulated material
raw material handling
caking and clumping
manufacturing efficiency
protein a resin
scale-up development
virusexpress™ lentiviral production platform
mobius® single-use bioreactors
templated manufacturing process
suspension-based lentivirus production
bioreactor process
scalable upstream bioreactor process
lentiviral vector production
filament-based
hot melt extrusion process
pharmaceutical industry
pharmaceutical manufacturing
pharmaceutical dosage
pharmaceutical dosage forms
additive manufacturing
formulation development
microbial retention
sterilizing filters
filter validation
aggregates
perfusion technologies
perfusate
viral contaminant
cell banks
bio4c™ processpad data management software
biocontinuum™
bioprocess lifecycle management
process verification (cpv)
data visualization & analysis
bio4c™ processpad
advanced analytics
smart data management
bio4c™
chromatography resin
monoclonal antibody purification
preparative chromatography
analytical chromatography
oxygen mass transfer
clinical scale
bench scale
bioreactors
filter selection
biopharm
fed-batch production
high-viscosity tff
reverse osmosis
nanofiltration
fda regulatory guidance
rcl testing
lentivirus testing
biosafety and characterization testing
foot and mouth (fmd) disease
virus retention
contamination
mrna production process
mrna delivery systems
therapeutics
single-use manufacturing
antibody drug conjugates
e. coli
recombinant growth factor
technically unavoidable particles
tupps
chemicals
pharmaceuticals
coriolis
recombinant
npi
pharmaceutical-grade sucrose
intein
affinity capture
discovery
continuous virus inactivation
intensified capture
next-generation bioprocessing
filter plugging
bulk filtration
downstream unit operations
scalable purification
data driven
biopharma manufacturing
compressibility
bulk density
flow
continuous tablet manufacturing
microbial contamination
tank cycling
flexible manufacturing
continuous diafiltration
excipients in china
excipient regulations
biosolve
cost of goods sold
process model
viral vectors
sars-cov2
mers
ebola
h1n1 influenza
corona virus
outbreak
global health challenges
pandemic
vaccine production
fouling model
vmax method
pmax method
bpsa
perfusion bioreactor
single-pass tangential flow filtration
virology
sedimentation velocity analytical ultracentrifugat
virus assay
cell assay
viral genome
viral capsids
auc assay
tableting
sustained release
fast track approach
• data visualization
• cpv
• continued process verification
• laboratory information management system (lims)
• manufacturing execution system (mes)
• enterprise resource planning (erp)
• biopharmaceutical processes
• data management
• next-generation bioprocessing
• software analytics
• software and automation
• integrated solutions
hdx mass spectrometry
peg linkers
spectroscopy
acoustic cell processing
cell therapy manufacturing
blazar
viral screening
bioinformatics
next generation sequencing
rapid molecular method
biologic therapy
lai
long-acting injectable microparticle
targeted drug delivery
rna delivery
rna vaccines
rna therapeutics
generating tumor-associated antigen panels
novel cell models
genome editing technology
engineered cell line
engineered custom cell line
immunotherapeutics
immunotherapy research
immunotherapy
antigen cell lines
batch release
closed manufacturing
closed sampling
perfused seed train
excipient risk assessment
integrated systems
perfusion filter
n-1
novel perfusion
cryopreservation
analytical development
titer
big data
supply chain risks
facility intensification
buffer delivery
process monitoring
regulatory compliant
continued process verification
cpv
purification template
disposable technology
continuous chromatography
biosimilar mab
horizon2020
virus spiking
api registration
cgt
formula
single-use connectors
single-use assemblies
integrity testers
cell & gene therapy (cgt) services
biopharm ingredients
msat
post approval changes
pei
eu commision
falsified medicine directive
regulations
chinese regulation
intensified mab purification
preclinical stage
clone selection
biopharma training
apac
emerging markets
efficiency in media preparation
compaction of cell culture media and single chemic
buffer concentrates
footprint saving buffer management
cell lines
cell culture media and supplements
multi-use systems hardware
platform assay
platform manufacturing
slc
scale-up
solubility
activated polyethylene glycols
polyethylene glycols
liphophilic payload
pk/pd
monodisperse
linkers
clinical trial
kla
process scalability
bioprocess international
map/hap
supply robustness
forecast
collaborative forecasting
phenylketonuria
gmp manufacturing
glycosylation
mass spectometry
n-glycan profiling of monoclonal antibodies
potency
white paper
prefilter
bioprocesing
intravenous immunoglobulin
ivig purification
process optimization
drug approval
accelerate product certification
pasteurization
viral risk mitigation
htst
small molecule series
smallmoleculeseries
pla/plga polymersmall molecules
optimum polymer technologyformulation technologies
synbiosys® multi-block polymer introductionparente
polymer based drug delivery systems
polymer based parenteral controlled-release drug d
particles
biodevelopment
synthetic lipids
philipp buehle
2d data matrix barcode
2d barcode
barcode
drug manufacturer
raw material supplier
raw materialsr
digital innovation
dna vectors
douglas bowman
appropriate quality
martin wisher
human vaccine
virus harvest
virus seed
vaccine cell bank
business plan
zfn
funding
corporate funding
startup
venture capital
alison armstrong
expression systems
viral risk
process sampling
novaseptum
ich q10
genotoxicity
serum free media
fetal bovine serum
bioassays
small-molecule api
drypour
mobius
virus contamination
modified expression systems
clean rooms
stainless steel
ttc
elsie
media prep
filter sizing
high throughput screening
viral filtration
biochemical technology
Tout plus
- Présentations
- Documents
- Infographies